Royce & Associates LP Boosts Stock Position in Varex Imaging Co. (NASDAQ:VREX)

Royce & Associates LP grew its holdings in Varex Imaging Co. (NASDAQ:VREX) by 70.4% during the fourth quarter, HoldingsChannel.com reports. The firm owned 746,770 shares of the company’s stock after acquiring an additional 308,629 shares during the quarter. Royce & Associates LP’s holdings in Varex Imaging were worth $10,895,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. FMR LLC increased its stake in Varex Imaging by 4,739.2% in the 3rd quarter. FMR LLC now owns 200,341 shares of the company’s stock worth $2,388,000 after buying an additional 196,201 shares during the period. Barclays PLC increased its position in shares of Varex Imaging by 15.3% during the third quarter. Barclays PLC now owns 97,883 shares of the company’s stock worth $1,166,000 after acquiring an additional 12,966 shares during the period. Point72 Asset Management L.P. bought a new stake in shares of Varex Imaging during the third quarter valued at approximately $415,000. BNP Paribas Financial Markets boosted its holdings in shares of Varex Imaging by 1,359.9% in the third quarter. BNP Paribas Financial Markets now owns 52,295 shares of the company’s stock valued at $623,000 after purchasing an additional 48,713 shares during the period. Finally, Weiss Asset Management LP bought a new position in Varex Imaging in the third quarter worth approximately $2,593,000.

Varex Imaging Stock Up 2.6 %

Shares of NASDAQ VREX opened at $12.82 on Tuesday. Varex Imaging Co. has a 12-month low of $10.19 and a 12-month high of $18.30. The stock’s fifty day simple moving average is $13.35 and its two-hundred day simple moving average is $13.42. The stock has a market capitalization of $528.18 million, a PE ratio of -10.96 and a beta of 0.56. The company has a current ratio of 4.36, a quick ratio of 2.50 and a debt-to-equity ratio of 1.02.

Varex Imaging (NASDAQ:VREX) last posted its earnings results on Thursday, February 6th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. As a group, analysts expect that Varex Imaging Co. will post 0.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Oppenheimer decreased their target price on Varex Imaging from $30.00 to $23.00 and set an “outperform” rating for the company in a research report on Friday, February 7th. StockNews.com raised shares of Varex Imaging from a “hold” rating to a “buy” rating in a research note on Friday, February 7th. Finally, B. Riley reissued a “buy” rating and set a $22.00 target price (up previously from $21.00) on shares of Varex Imaging in a research report on Friday, February 7th.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.